I agree that this site is using cookies. You can find further informations here.
X
Patorno, E.
36  results:
Search for persons X
?
1

EMPRISE: efficacité cardiovasculaire de l'empagliflozine ch..:

Patorno, E. ; Tesfaye, H. ; Wexler, D.J....
Annales d'Endocrinologie.  82 (2021)  5 - p. 266-267 , 2021
Link: https://doi.org/10.1016/..
 
?
2

Empagliflozin selected cardiovascular and safety outcomes i..:

Patorno, E. ; Pawar, A. ; Franklin, J.M....
Metabolism.  104 (2020)  - p. 154126 , 2020
Link: https://doi.org/10.1016/..
 
?
3

Application of a Medicare claims-based model predicting lef..:

Desai, R.J ; Mahesri, M ; Chin, K...
European Heart Journal.  41 (2020)  Supplement_2 - p. , 2020
Link: https://doi.org/10.1093/..
 
?
4

P5003Reduced healthcare utilization in routine care initiat..:

Pawar, A ; Patorno, E ; Deruaz-Luyet, A...
European Heart Journal.  40 (2019)  Supplement_1 - p. , 2019
Link: https://doi.org/10.1093/..
 
?
5

PDB126 COMPARATIVE HEALTHCARE COSTS AND MEDICATION BURDEN I..:

Pawar, A. ; Patorno, E. ; Déruaz-Luyet, A....
Value in Health.  22 (2019)  - p. S161 , 2019
Link: https://doi.org/10.1016/..
 
?
6

PDB128 REDUCED HEALTHCARE UTILIZATION IN PATIENTS USING EMP..:

Najafzadeh, M. ; Pawar, A. ; Déruaz-Luyet, A....
Value in Health.  22 (2019)  - p. S161 , 2019
Link: https://doi.org/10.1016/..
 
?
7

PCV78 RISK FACTORS FOR DECOMPENSATION AND CARDIOVASCULAR MO..:

Desai, R. ; Lin, J. ; Patorno, E....
Value in Health.  22 (2019)  - p. S133 , 2019
Link: https://doi.org/10.1016/..
 
?
8

COMPARATIVE SAFETY OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS AND..:

Sultana, J ; Kim, D ; Huybrechts, K...
Innovation in Aging.  2 (2018)  suppl_1 - p. 853-853 , 2018
Link: https://doi.org/10.1093/..
 
?
9

BENZODIAZEPINES AND THE RISK OF ALL-CAUSE MORTALITY IN OLDE..:

Patorno, E ; Glynn, R J ; Levin, R.
Innovation in Aging.  2 (2018)  suppl_1 - p. 852-853 , 2018
Link: https://doi.org/10.1093/..
 
?
10

Comparative cardiovascular safety of glucagon-like peptide-..:

Patorno, E. ; Everett, B. M. ; Goldfine, A. B....
Diabetes, Obesity and Metabolism.  18 (2016)  8 - p. 755-765 , 2016
Link: https://doi.org/10.1111/..
 
?
11

Patients' perception about risks and benefits of antithromb..:

Najafzadeh, M. ; Kim, S. C. ; Patterson, C....
BMC Musculoskeletal Disorders.  16 (2015)  1 - p. , 2015
Link: https://doi.org/10.1186/..
 
?
12

Patterns of Treatment adherence in Patients with type 2 Dia..:

Patorno, E. ; Gopalakrishnan, C. ; Zorina, O....
Value in Health.  18 (2015)  3 - p. A57 , 2015
Link: https://doi.org/10.1016/..
 
?
13

PHP9 THE IMPACT OF LEGISLATION AND PRICING ON GENERIC DRUG ..:

Patorno, E ; Margulis, A ; Cai, S...
Value in Health.  12 (2009)  3 - p. A80 , 2009
Link: https://doi.org/10.1016/..
 
?
14

PPARA polymorphism influences the cardiovascular benefit of..:

Morieri M. L ; Shah H. S ; Sjaarda J...
info:eu-repo/semantics/altIdentifier/pmid/31974142.  , 2020
Link: http://hdl.handle.net/11..
 
?
15

Risk Factors for Heart Failure with Preserved or Reduced Ej..:

Lee MP ; Glynn RJ ; Schneeweiss S...
https://www.dovepress.com/risk-factors-for-heart-failure-with-preserved-or-reduced-ejection-frac-peer-reviewed-article-CLEP.  , 2020
Link: https://doaj.org/article..
 
1-15